Upgrade to SI Premium - Free Trial

Aprea Therapeutics (APRE)

0.79 -0.02 (2.47%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/5/26)

Latest Headlines

Form 8-K Aprea Therapeutics, Inc. For: Aug 28 August 28, 2026 8:30 AM - SEC Filing Aprea Therapeutics updates patent portfolio to 28 issued patents August 28, 2026 8:16 AM - StreetInsider Aprea Therapeutics Announces Expansion of Intellectual Property Portfolio for Precision Oncology Programs August 28, 2026 8:15 AM - StreetInsider Form SCHEDULE 13G/A Aprea Therapeutics, Inc. Filed by: LYTTON LAURENCE W August 13, 2026 2:27 PM - SEC Filing Form 10-Q Aprea Therapeutics, Inc. For: Jun 30 August 12, 2026 8:41 AM - SEC Filing Form 8-K Aprea Therapeutics, Inc. For: Aug 12 August 12, 2026 8:35 AM - SEC Filing Aprea Therapeutics Announces Second Quarter 2026 Financial Results August 12, 2026 8:30 AM - StreetInsider Lipocine names former Johnson & Johnson executive to its board August 3, 2026 8:00 AM - StreetInsider Lipocine Appoints Michael J. Grissinger to Board of Directors August 3, 2026 8:00 AM - PR NewsWire Aprea expands cancer trial sites and plans Q4 2026 data update July 30, 2026 8:01 AM - StreetInsider Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026 July 30, 2026 8:00 AM - StreetInsider Form 8-K Aprea Therapeutics, Inc. For: Jul 23 July 23, 2026 4:05 PM - SEC Filing Next-Generation DNA Repair Therapies Open New Frontiers in Oncology June 22, 2026 8:30 AM - StreetInsider Form 4 Aprea Therapeutics, Inc. For: Jun 16 Filed by: Grissinger Michael June 17, 2026 7:10 PM - SEC Filing Form 4 Aprea Therapeutics, Inc. For: Jun 16 Filed by: Gruia Gabriela June 17, 2026 7:08 PM - SEC Filing Form 4 Aprea Therapeutics, Inc. For: Jun 16 Filed by: Peters Richard June 17, 2026 7:07 PM - SEC Filing Form 4 Aprea Therapeutics, Inc. For: Jun 16 Filed by: HENNEMAN JOHN B III June 17, 2026 7:06 PM - SEC Filing Form 4 Aprea Therapeutics, Inc. For: Jun 16 Filed by: BIZZARI JEAN-PIERRE June 17, 2026 7:05 PM - SEC Filing Form 4 Aprea Therapeutics, Inc. For: Jun 16 Filed by: Duey Marc June 17, 2026 7:04 PM - SEC Filing Form 4 Aprea Therapeutics, Inc. For: Jun 16 Filed by: Pamukcu Rifat June 17, 2026 7:03 PM - SEC Filing Form 4 Aprea Therapeutics, Inc. For: Jun 16 Filed by: Seizinger Bernd R. June 17, 2026 7:03 PM - SEC Filing Form 8-K Aprea Therapeutics, Inc. For: Jun 16 June 17, 2026 4:16 PM - SEC Filing Full Article List